Wang Hao is the deputy director of the Department of Neurosurgery, Hangzhou First People's Hospital, Zhejiang University School of Medicine, associate professor, and master Tutor. "131" talent in Hangzhou, youth member of Zhejiang Anti-Cancer Association, member of Spine and Spinal Medicine Group of Neurosurgery Branch of Zhejiang Medical Association, member of Zhejiang Craniocerebral Injury Rehabilitation Association, member of Zhejiang Medical Appraisal Expert Bank, Hangzhou Medical Association Young member of the Surgery Branch, Huashan Hospital of Fudan University received a doctorate in neurosurgery.
Engaged in neurosurgery for 15 years, is good at minimally invasive diagnosis and treatment of cerebrovascular diseases, and has accumulated rich experience in the treatment of cerebrovascular diseases. For complicated intracranial aneurysms, endovascular stent-assisted embolization technology is used to perform individualized intracranial and extracranial vascular reconstruction for patients with moyamoya disease, and more than 1,000 operations for various cerebrovascular diseases have been completed, with good social benefits. A key innovative technology of microvascular decompression for the treatment of trigeminal neuralgia was first proposed by him in the authoritative journal of international neurosurgery, which improved the efficacy of surgery and greatly reduced the risk of surgery. He has successively obtained 4 provincial and ministerial project funding as the first applicant, and published more than 10 academic papers at home and abroad, including 5 papers included in SCI, and 2 national utility model patents.
Major specializations: 1. Intervention of cerebrovascular disease and microsurgical treatment of moyamoya disease. 2. Microvascular decompression to treat trigeminal neuralgia, hemifacial spasm, glossopharyngeal neuralgia. 3. Microsurgical treatment of brain tumors, spinal cord and peripheral nerve diseases.